Current established BC treatment options include chemotherapy (CT), endocrine therapy (ET), radiation therapy (RT), as well as targeted therapies (reviewed in [55,154]), which are selected based on HR and HER2 status. The gene discussed is ERBB2; the disease is breast cancer.